Biotech2 days ago
Spain Approves Groundbreaking Genetic ALS Treatment Tofersen for Public Use
Spain’s health ministry has approved funding for Tofersen (Qalsody), the first EU-approved drug targeting a genetic cause of ALS—SOD1 mutations. This personalized therapy silences the gene...